| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |